These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New blocking agent against the development of LSD-25 psychosis. FABING HD Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971 [No Abstract] [Full Text] [Related]
3. Model psychoses induced by LSD-25 in normals. II. Rorschach test findings. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):612-8. PubMed ID: 13325990 [No Abstract] [Full Text] [Related]
4. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989 [No Abstract] [Full Text] [Related]
5. Experimental compound mer-17 (frenquel): a new blocking agent against the development of LSD-25 psychosis. FABING HD Trans Am Neurol Assoc; 1955-1956; (80th Meeting):83-5. PubMed ID: 13312008 [No Abstract] [Full Text] [Related]
6. [EFFECT OF NICOTINIC ACID ON EXPERIMENTAL PSYCHOSES INDUCED WITH LYSERGIC ACID DIETHYLAMIDE]. IVANOVA RA; MILSHTEIN GI; SMIRNOVA LB; FANCHENKO ND Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1172-6. PubMed ID: 14244572 [No Abstract] [Full Text] [Related]
7. [Body scheme disorders in lysergic acid diethylamide]. ARNOLD OH; HOFF H Wien Z Nervenheilkd Grenzgeb; 1953; 6(4):259-74. PubMed ID: 13078611 [No Abstract] [Full Text] [Related]
8. Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148). GINZEL KH; MAYER-GROSS W Nature; 1956 Jul; 178(4526):210. PubMed ID: 13348662 [No Abstract] [Full Text] [Related]
9. Psychophysiological investigations in experimental psychoses; results of the exhibition of d-lysergic acid diethylamide to psychiatric patients. SLOANE B; DOUST JW J Ment Sci; 1954 Jan; 100(418):129-44. PubMed ID: 13152528 [No Abstract] [Full Text] [Related]
10. [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine]. GIBERTI F; GREGORETTI L Sist Nerv; 1955; 7(4):301-10. PubMed ID: 13290891 [No Abstract] [Full Text] [Related]
11. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application. FABING HD Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384 [No Abstract] [Full Text] [Related]
12. Effects of experimentally induced psychoses on artistic expression. TONINI G; MONTANARI C Confin Neurol; 1955; 15(4):225-39. PubMed ID: 13305222 [No Abstract] [Full Text] [Related]
13. [Contribution to the psychopathological study of the effects of lysergic acid monoethylamide]. CALLIERI B; RAVETTA M Arch Psicol Neurol Psichiatr; 1956; 17(1):43-79. PubMed ID: 13341385 [No Abstract] [Full Text] [Related]
14. Experimental psychiatry. II. Clinical and physio-chemical observations in experimental psychosis. RINKEL M; HYDE RW; SOLOMON HC; HOAGLAND H Am J Psychiatry; 1955 Jun; 111(12):881-95. PubMed ID: 14376656 [No Abstract] [Full Text] [Related]
15. [Lysergic acid ethylamide, a new ergot drug strongly sedative effect causing psychotic states]. SOLMS H Schweiz Med Wochenschr; 1953 Apr; 83(15):356-60. PubMed ID: 13076048 [No Abstract] [Full Text] [Related]
16. Dissociation constants of some compounds related to lysergic acid; Beta-dimethylaminopropionic acid, dihydroarecaidine, ecgonine and their derivatives. CHILTON J; STENLAKE JB J Pharm Pharmacol; 1955 Dec; 7(12):1004-11. PubMed ID: 13278846 [No Abstract] [Full Text] [Related]
17. [Etiology of psychoses of the acute, exogenous reaction type; diethylamide of lysergic acid, a toxic trace element with psychic effects]. BLICKENSTORFER E Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1952; 188(3):226-36. PubMed ID: 12977367 [No Abstract] [Full Text] [Related]